rs406238

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000129.4(F13A1):​c.1747+2511T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.657 in 152,152 control chromosomes in the GnomAD database, including 33,807 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.66 ( 33807 hom., cov: 33)

Consequence

F13A1
NM_000129.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.53

Publications

5 publications found
Variant links:
Genes affected
F13A1 (HGNC:3531): (coagulation factor XIII A chain) This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
F13A1 Gene-Disease associations (from GenCC):
  • factor XIII, A subunit, deficiency of
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
  • congenital factor XIII deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.81 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F13A1NM_000129.4 linkc.1747+2511T>G intron_variant Intron 12 of 14 ENST00000264870.8 NP_000120.2 P00488

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F13A1ENST00000264870.8 linkc.1747+2511T>G intron_variant Intron 12 of 14 1 NM_000129.4 ENSP00000264870.3 P00488

Frequencies

GnomAD3 genomes
AF:
0.656
AC:
99801
AN:
152034
Hom.:
33755
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.817
Gnomad AMI
AF:
0.586
Gnomad AMR
AF:
0.518
Gnomad ASJ
AF:
0.660
Gnomad EAS
AF:
0.601
Gnomad SAS
AF:
0.706
Gnomad FIN
AF:
0.660
Gnomad MID
AF:
0.783
Gnomad NFE
AF:
0.590
Gnomad OTH
AF:
0.665
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.657
AC:
99904
AN:
152152
Hom.:
33807
Cov.:
33
AF XY:
0.659
AC XY:
49040
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.817
AC:
33933
AN:
41530
American (AMR)
AF:
0.517
AC:
7897
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.660
AC:
2291
AN:
3472
East Asian (EAS)
AF:
0.601
AC:
3112
AN:
5176
South Asian (SAS)
AF:
0.709
AC:
3415
AN:
4820
European-Finnish (FIN)
AF:
0.660
AC:
6983
AN:
10574
Middle Eastern (MID)
AF:
0.788
AC:
230
AN:
292
European-Non Finnish (NFE)
AF:
0.590
AC:
40106
AN:
67984
Other (OTH)
AF:
0.664
AC:
1403
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1733
3466
5200
6933
8666
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
788
1576
2364
3152
3940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.609
Hom.:
125801
Bravo
AF:
0.647
Asia WGS
AF:
0.672
AC:
2338
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.17
DANN
Benign
0.48
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs406238; hg19: chr6-6172302; API